Activation of the Kynurenine Pathway in the Acute Phase of Stroke and its Role in Fatigue and Depression Following Stroke

Journal of Molecular Neuroscience

Volumn 54, Issue 2, 2014, Pages 181-187

  Ormstad, Heidi ^a,b   Verkerk, Robert ^c   Amthor, Karl Friedrich ^b   Sandvik, Leiv ^d  

^a UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^b Vestre Viken Hospital   (Norway)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute ischemic stroke; Cytokines; Kynurenine pathway; Poststroke depression; Poststroke fatigue

Indexed keywords

BIOLOGICAL MARKER; KYNURENINE; SEROTONIN; TRYPTOPHAN;

ADULT; AGED; BLOOD; BRAIN ISCHEMIA; CASE CONTROL STUDY; COMPLICATION; DEPRESSION; FATIGUE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; DEPRESSION; FATIGUE; FEMALE; HUMANS; KYNURENINE; MALE; MIDDLE AGED; PROGNOSIS; SEROTONIN; STROKE; TRYPTOPHAN;

EID: 84896427247     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0272-0     Document Type: Article

References (48)

1. Aben I et al (2002) Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics 43:386–393
2. Adams HP Jr et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
3. Anderson GM et al (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28:885–900
4. Anderson G, Maes M, Berk M (2012) Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome. Med Hypotheses 78:752–756
5. Ayerbe L et al (2013) Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 202:14–21
6. Barker-Collo S, Feigin VL, Dudley M (2007) Post stroke fatigue—where is the evidence to guide practice? N Z Med J 120:U2780
7. Beck AT et al (1996) Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67:588–597
8. Choi-Kwon S et al (2005) Poststroke fatigue: characteristics and related factors. Cerebrovasc Dis 19:84–90
9. Dantzer R (2009) Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 29:247–264
10. Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153–160
11. Duncan F, Wu S, Mead GE (2012) Frequency and natural history of fatigue after stroke: a systematic review of longitudinal studies. J Psychosom Res 73:18–27
12. Eilertsen G, Ormstad H, Kirkevold M (2013) Experiences of poststroke fatigue: qualitative meta-synthesis. J Adv Nurs 69:514–525
13. Fang J, Cheng Q (2009) Etiological mechanisms of post-stroke depression: a review. Neurol Res 31:904–909
14. Fernstrom JD (1983) Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 63:484–546
15. Gold AB et al (2011) The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflammation 8:17
16. Hackett ML et al (2008) Interventions for preventing depression after stroke. Cochrane Database Syst Rev CD003689
17. Heesen C et al (2006) Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 77:34–39
18. Herve C et al (1996) Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B Biomed Appl 675:157–161
19. Ingles JL, Eskes GA, Phillips SJ (1999) Fatigue after stroke. Arch Phys Med Rehabil 80:173–178
20. Krupp LB et al (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123
21. Kurz K et al (2012) Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown. PLoS One 7:e36956
22. Lerdal A., et al. (2012) The course of fatigue during the first 18months after first-ever stroke: a longitudinal study. Stroke research and treatment. 2012, 126275
23. Levin SG, Godukhin OV (2011) Anti-inflammatory cytokines, TGF-beta1 and IL-10, exert anti-hypoxic action and abolish posthypoxic hyperexcitability in hippocampal slice neurons: comparative aspects. Exp Neurol 232:329–332
24. Maes M et al (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10:66
25. Markus CR et al (2005) Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr 81:1026–1033
26. McGeough E. et al. (2009) Interventions for post-stroke fatigue. Cochrane Database Syst Rev. CD007030
27. Menzies V, Lyon DE (2010) Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biol Res Nurs 11:387–394
28. Michael KM, Allen JK, Macko RF (2006) Fatigue after stroke: relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy. Rehabil Nurs 31:210–217
29. Monti JM (2011) Serotonin control of sleep-wake behavior. Sleep Med Rev 15:269–281
30. Morris G. Maes M. (2012) A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. Metab Brain Dis
31. Naess H et al (2005) Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc Dis 20:245–250
32. Naess H et al (2006) Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke 37:1232–1236
33. Ormstad H et al (2011a) Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol 258:670–676
34. Ormstad H et al (2011b) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677–685
35. Ormstad H et al (2012) Serum levels of cytokines, glucose, and hemoglobin as possible predictors of poststroke depression, and association with poststroke fatigue. Int J Neurosci 122:682–690
36. Ormstad H. et al. (2013) Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke. J Mol Neurosci
37. Rocha e Silva CE et al (2013) Is poststroke depression a major depression? Cerebrovasc Dis 35:385–391
38. Scalzo P et al (2010) Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance. Neurosci Lett 468:56–58
39. Schepers VP et al (2006) Poststroke fatigue: course and its relation to personal and stroke-related factors. Arch Phys Med Rehabil 87:184–188
40. Schroecksnadel K et al (2007) Diminished quality of life in patients with cancer correlates with tryptophan degradation. J Cancer Res Clin Oncol 133:477–485
41. Segev-Amzaleg N, Trudler D, Frenkel D (2013) Preconditioning to mild oxidative stress mediates astroglial neuroprotection in an IL-10-dependent manner. Brain Behav Immun 30:176–185
42. Seruga B et al (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887–899
43. Spalletta G et al (2006) The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 11:984–991
44. Stoll G, Jander S, Schroeter M (2000) Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 59:81–89
45. Swartz KJ et al (1990) Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 10:2965–2973
46. Turnell DC, Cooper JD (1982) Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem 28:527–531
47. van der Werf SP et al (2001) Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur Neurol 45:28–33
48. Yamamoto T, Azechi H, Board M (2012) Essential role of excessive tryptophan and its neurometabolites in fatigue. Can J Neurol Sci 39:40–47